Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
Just nowOrchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
56m agoWestinghouse eVinci™ Microreactor Selected for Malmstrom Air Force Base
57m agoSTANDEX DECLARES 247th CONSECUTIVE QUARTERLY DIVIDEND
58m agoi3 Verticals Announces Earnings Release and Conference Call Date for Second Quarter of Fiscal 2026
58m agoWorld Acceptance Corporation Announces Fourth Quarter 2026 Conference Call on the Internet
Orchestra Biomed Holdings Inc. logo

Orchestra Biomed Holdings Inc.

About

Orchestra Biomed Holdings Inc. (NASDAQ:OBIO) — investor relations, events, news, and company updates on 6ix.

Latest News

Today
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
Mar 12 2026
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Mar 3 2026
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
Feb 13 2026
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 12 2026
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

Financials

Revenue
$33.48 M
Market Cap
$248.13 M
EPS
-1.11

Community Chat

Ask AI

6ix6ix